Here's the complete Addendum replacement — current through today's full session. Paste this as a full replacement of the existing content.
PIVOT PROTOCOLS — LIVING ADDENDUM Document 2 of 2 · Updated Every Session · Replace Completely Each Time Last Updated: March 28, 2026 · Always fetch alongside Core Reference (Document 1)
Featured Positioning Statements — Locked
INTERNAL / STRATEGIC USE ONLY — NEVER PUBLIC FACING "The site is the map. The program is the territory. The map is free. The territory costs."
PUBLIC-FACING VERSION — USE IN SALES COPY, HOMEPAGE, ABOUT "The site gives you the framework. The program delivers the exit." Alternate: "Understanding the trap is free. Getting out takes a guide."
Usage rule: Internal statement appears in attorney briefing, investor/acquirer pitch, book proposal, and strategic documents. Public-facing versions appear on program sales page, about page, homepage, and any user-facing copy. Never mix.
Northstar Vision — Locked
Pivot Protocols is a protocol-driven behavioral system with a high-intent organic acquisition engine and a proprietary intake and trajectory architecture (SmartGate + VDI) capable of expanding across multiple behavioral and decision-driven verticals. Pivot Protocols is the proving ground. SmartGate and VDI are the infrastructure. BCaaS is the expansion layer.
Current Build Status
COMPLETE 75+ page content library COMPLETE Quit Plan Builder / VDI Tool — SmartGate routing logic refined and confirmed as brilliant closing mechanism COMPLETE SmartGate Screening Tool — built and ready to embed COMPLETE PCO Program V3.1 internal document COMPLETE Retail Pharmacology Thesis document COMPLETE PAWS content cluster — anhedonia, cognitive fog, emotional dysregulation, hub page COMPLETE Program Guide PDF — branded, all sections, live site links embedded COMPLETE Clinical Conversation Framework PDF — branded, comfort medications, pharmacy guidance COMPLETE Homepage reframe — Kinetic Exit as primary offer, two-CTA architecture COMPLETE Program page reframe — leaf/extract unified, compression cycle language, $800 pricing COMPLETE How It Works — full rewrite March 28, super tight conversion page, loss of control and need to feel normal as spine, two-CTA architecture (Kinetic Exit + QPT), supplement framing for family members, gives everyone a way out of blame COMPLETE Who This Is For — updated, QPT present COMPLETE FAQ page — updated COMPLETE Core Concepts page — updated COMPLETE Navigation updated — Kinetic Exit as primary nav item COMPLETE GBAD page — full definitive rewrite March 28, emotional dimension fully integrated as equal architecture, physical and emotional dimensions both grounded in peer-reviewed science, 3 citations inline, 8 internal links, author block, QPT closing block added COMPLETE CCOD page — full definitive rewrite March 28, emotional dimension fully integrated, "The pattern is the tell" section with breakthrough clinical distinction, 2 citations inline, 7 internal links, progression note, author block, QPT closing block added COMPLETE COWS page — full rewrite March 28, emotional gap added alongside physical gap, precision refinement on GI symptom timing, Broyan et al. citation, 7 internal links, author block COMPLETE PCO page — full rewrite March 28, crowning achievement of Pivot Protocols, two-dimension overwrite argument, saturation argument grounded in 7-OH tolerance science, MAT distinction, original use case recovery framing, 9 internal links COMPLETE Activation Slope Induction page — readability rewrite applied COMPLETE Persistent Pathway page — readability rewrite applied, all scientific edits applied COMPLETE Protecting the Post-Exit Window hub page — /protecting-the-post-exit-window COMPLETE Smartphones and Early Recovery page — /smartphones-early-recovery COMPLETE Vaping and Early Recovery page — /vaping-early-recovery COMPLETE Library updated — all new pages added COMPLETE CCOD rename executed — slug /compressed-cycle-opioid-dependence live, internal links updated COMPLETE CSS fix live — .sqs-html-content p { margin-bottom: 0.4em; margin-top: 0.4em; } COMPLETE Retail Pharmacology Part Three — title updated to "Compressed-Cycle Opioid Dependence and the Tightening Loop" COMPLETE Short Cycle Hell — QPT present COMPLETE Stability Framework — QPT present COMPLETE QPT — confirmed as brilliant soft close mechanism after logic refinement. Now deployed across all high-intent acquisition pages IN PROGRESS Enrollment page — payment + Day 1 scheduling IN PROGRESS Attorney outreach — Cohen and Redemption House counsel IN PROGRESS Terms of Service — skeleton ready for review IN PROGRESS Privacy Policy — draft ready for review NEXT PCO Bridge product page NEXT B2B one-pager for treatment center referral outreach NEXT About page reframe NEXT PAWS pages — QPT closing block to be added with appropriate framing for mixed reader (some post-exit, some still in pattern) PLANNED Filter follow-up — Kastalia Medrano, check timing from March 2026 pitch PLANNED STAT News — resolve AI disclosure question PLANNED Kevin MVP conversation — SmartGate, VDI dashboard, group call infrastructure PLANNED PCO Parts 4 and 5 — kindled nervous system and harm reduction framing PLANNED Essays cleanup — Kindled Market and Partial Agonist vs Full Agonist need CCOD rename and author block update. Voice intentional — do not rewrite.
Terminology — Locked
CCOD — Compressed-Cycle Opioid Dependence. Replaces SCOD everywhere. Slug /compressed-cycle-opioid-dependence live. Internal links updated. Retail Pharmacology Part Three title updated.
GBAD — G-protein Biased Autonomic Dysregulation. Ownership claim is the mechanistic framework and clinical implications, not the symptoms themselves. Namespace confirmed empty.
Kinetic Exit — the 30-day program. Phase One: The Exit (Days 1–14). Phase Two: The Landing (Days 15–30). App name: Kinexit. Program slug: /quit-7oh-kratom-program.
BCaaS — Behavioral Containment as a Service. Scaling vision.
Major Framework Decisions — Locked March 28
PCO page — crowning achievement of Pivot Protocols. Two-dimension overwrite: pharmacological (sawtooth deletion) and neurophysiological (cycle reorganization interrupted). Saturation argument grounded in 7-OH tolerance and compression cycle science — standard titration undershoots this population. Confirmation mechanism — no perceptible effect — is the clinical signal not a fixed dose number. MAT distinction locked. Original use case recovery framing.
GBAD + CCOD emotional dimension — breakthrough integration March 28. The mu-opioid system is a primary regulator of emotional tone, grief processing, and stress response (Zubieta JK et al., Arch Gen Psychiatry, 2003; Hsu DT et al., Molecular Psychiatry, 2013). When kratom alkaloids and 7-OH clear every two to three hours, emotional regulatory function clears with them.
Breakthrough clinical distinction — locked March 28: "If the emotional drops arrive reliably between doses and resolve reliably when the dose lands — that's not a mood disorder. That's the mu-opioid system's emotional regulatory function cycling with the pharmacokinetics." Lives in CCOD "The pattern is the tell" section. The schedule is the evidence.
COWS gap argument — precision refined March 28. GI symptoms not absent from withdrawal picture entirely — absent in the early descending activation window (2-3 hours post-dose) that is the PCO induction target. COWS calibrated for a withdrawal arc that takes 12-24 hours to develop. This population's induction window closes before that arc can form. Emotional dimension of GBAD doesn't appear on COWS at all.
Saturation argument — grounded March 28. 7-OH tolerance built through compression cycle — high potency compound (13x morphine, Takayama et al. 2002), continuous activation without inter-dose recovery windows. Direct clinical observation: 250-300mg daily, 15mg every 2hrs controlled symptoms — timing drove pattern more than dose size. Confirmation mechanism — no perceptible effect — is the clinical signal.
How It Works conversion architecture — locked March 28. Loss of control and need to feel normal as the spine. Two-CTA architecture: Kinetic Exit (ready reader) + QPT (almost-ready reader). Supplement framing for family members — gives everyone a way out of blame. No author block — conversion page not clinical framework. One external link only.
QPT as closing mechanism — confirmed brilliant March 28. After logic refinement QPT now routes correctly: strong fit to enrollment, almost ready to conversation, not ready to Stability Framework, crisis to 988. Deployed as soft close on all high-intent acquisition pages. Introduction: "If this pattern sounds familiar — this takes 30 seconds. No email required." PAWS pages need QPT with modified framing for mixed reader.
Author block — standard for all clinical framework pages: "John Leonard is the founder of Pivot Protocols and a recovery program leader with 23 years of front-line experience. The frameworks on this site were developed through direct observation, pattern recognition, and grounding in published pharmacological research. He is not a clinician or medical provider." Note: footer handles practice disclaimer sitewide. Page-level disclaimer reduced to: "This framework is offered for educational purposes only. All clinical decisions are made solely between the patient and their licensed medical provider."
SEO Rules — Locked
Anchor text rule: always anchor the full proprietary term. Always anchor the H1 of the target page. Full term anchors: Pharmacologic Cycle Overwrite, Activation Slope Induction, G-protein Biased Autonomic Dysregulation, Compressed-Cycle Opioid Dependence, Persistent Pathway, Kindled Market, Protecting the Post-Exit Window, Kinetic Exit.
Link notation in deliverables: Term → (/slug)
Meta descriptions under 155 characters. Site auto-appends "| Pivot Protocols" — never add manually.
Ask before rewriting — confirm specs, links, and citations before building any page.
Readability Architecture — 15 Rules Locked
All clinical framework pages built to 15-rule standard. Key rules: plain language section headers, translation lines every 2-3 paragraphs, standalone pull quotes, 3am test, dual audience, hopeful frame, mechanism-first.
Essays (Kindled Market, Partial Agonist, Retail Pharmacology series) — intentional different register. Do not apply clinical framework rules. Voice is literary and analytical. Leave alone except targeted CCOD/author block updates.
Citations In Regular Use
Takayama et al. 2002 — 7-OH 13x morphine potency in guinea pig ileum. In-vitro. Replicated by Hemby et al. 2019. Hemby SE et al. Addiction Biology. 2019;24(5):874-885 — 7-OH abuse liability and potency. Kruegel AC et al. Nature Communications. 2021 — G-protein bias of kratom alkaloids. Zubieta JK et al. Arch Gen Psychiatry. 2003;60:1145-53 — mu-opioid regulation of human affective responses. Kennedy SE et al. Arch Gen Psychiatry. 2006;63:1199-208 — endogenous opioid emotion regulation. Hsu DT et al. Molecular Psychiatry. 2013;18:1211-17 — mu-opioid system and social pain/grief processing. Pecina M et al. JAMA Psychiatry. 2015;72:1087-94 — opioid system and depression. Broyan, Brar, Allgaier et al. Substance Abuse. 2022 — 28 patients, zero precipitated withdrawal, kratom to buprenorphine. Wesson DR, Ling W. Journal of Psychoactive Drugs. 2003 — original COWS validation paper. SAMHSA TIP 63 — federal guidance, COWS ≥12 threshold recommendation.
Novelty Inventory — Confirmed
Strongest claims — fully defensible: Activation Slope Induction — descending activation curve as timing signal. Not in literature. CCOD as named clinical category — cycle frequency as defining variable. Not formally named before. PCO two-dimension overwrite — pharmacological sawtooth plus neurophysiological reorganization addressed simultaneously. GBAD emotional dimension — mu-opioid emotional regulatory function cycling with pharmacokinetics as withdrawal presentation. Grounded in peer-reviewed science, not previously applied to this population. "The pattern is the tell" — schedule-based differentiation of pharmacological emotional cycling from mood disorder. Original clinical observation. Persistent Pathway applied to this population — original synthesis. Kindled Market — cross-domain kindling as market analysis framework. SmartGate — directional intake routing based on pattern trajectory.
Content Architecture — Cluster Relationships
GBAD → COWS → Activation Slope Induction: sequential clinical arc. CCOD ↔ GBAD: reciprocal. CCOD names the pattern, GBAD names the withdrawal presentation. PCO hierarchy: Partial Agonist explains the science → PCO applies it → How It Works explains to patient → Program is the exit. Persistent Pathway → Protecting the Post-Exit Window → Smartphones / Vaping. Persistent Pathway ↔ Kindled Market: reciprocal.
QPT deployment — acquisition pages only. Not on clinical framework pages with prescriber/researcher primary audience. PAWS pages — add with modified framing acknowledging mixed reader.
Business Model — Locked
Kinetic Exit — $797 founding cohort pricing (listed as $800 on site). Exit target: $2-5M strategic sale at 18-24 months. Terminology moat — coining proprietary language before public launch is deliberate first-mover namespace play.
Key Relationships
John Curtiss — founder of The Retreat, 12-year mentor, backlink source, potential PCO clinical collaborator. Kastalia Medrano — journalist at Filter Magazine, pitch sent. Check 3-week timing from March 2026 pitch. Kevin Ferron — former Zynga developer, potential MVP co-founder. Michael H. Cohen — Cohen Healthcare Law Group (310) 844-3173. Healthcare attorney for program document review.
Technical — Live
CSS fix live: .sqs-html-content p { margin-bottom: 0.4em; margin-top: 0.4em; } Context documents: /master-context-core and /master-context-addendum Google Search Console configured and sitemap submitted. @PivotProtocols X account launched. Total pages in Squarespace editor: approximately 100. Live content pages: approximately 75.
Session Log
March 21, 2026 — Session 1 PCO V3.1 reviewed. Retail Pharmacology Thesis created. Anhedonia piece initiated. Book decision made. Two-document workflow system designed. Attorney identified. Full PCO terminology vault built.
March 21, 2026 — Session 2 Patient-led model framing established. Four-step patient protocol locked. Partial-to-partial onboarding insight locked. Telehealth layer documented. Protection architecture documented. Positioning statements locked.
March 24, 2026 — Session 3 Filter pitch sent to Kastalia Medrano. STAT News identified. Terms of Service skeleton drafted. SmartGate discovered and fully developed. SmartGate Core document entry locked. SmartGate Referral Pipeline concept locked.
March 25, 2026 — Session 4 Full site reframe executed. Homepage, program page, How It Works, Stability Framework, Who This Is For, FAQ, Core Concepts all updated. QPT tool updated with SmartGate routing. SmartGate Screening Tool built and deployed. Program Guide PDF and CCF PDF built. Six-Day PCO Bridge product concept locked. GBAD, Activation Slope Induction, COWS pages built and published.
March 26, 2026 — Session 5 Claude in Chrome extension connected — browser control workflow established. Both context documents pulled directly from live site. Persistent Pathway built. 15-rule readability architecture developed and applied. Protecting the Post-Exit Window hub built. Smartphones and Early Recovery built. Vaping and Early Recovery built. CCOD rename decision locked. SEO anchor text rule locked. Activation Slope Induction readability rewrite applied. Library updated. Novelty inventory confirmed. GBAD ownership language clarified.
March 27, 2026 — Session 6 PCO page — full rewrite, crowning achievement of Pivot Protocols. GBAD — full definitive rewrite with emotional dimension. CCOD — full definitive rewrite with emotional dimension. COWS — full rewrite. Author block standard locked. Ask before rewriting rule established. Link notation workflow confirmed.
March 28, 2026 — Session 7 How It Works — full rewrite, super tight conversion page. Loss of control and need to feel normal as spine. Two-CTA architecture locked — Kinetic Exit for ready reader, QPT for almost-ready reader. Supplement framing for family members — gives everyone a way out of blame. QPT confirmed as brilliant closing mechanism after logic refinement — deployed across all high-intent acquisition pages with introduction "If this pattern sounds familiar — this takes 30 seconds. No email required." QPT closing block added to CCOD and GBAD. Retail Pharmacology Part Three title updated to "Compressed-Cycle Opioid Dependence and the Tightening Loop." Page count confirmed at approximately 75 live content pages. Essays reviewed — voice intentional, leave alone except targeted updates. PAWS pages — QPT needed with modified framing for mixed reader (next session). Full PCO-linked page set now complete and live in new voice.
Next Session Priority Order
PAWS pages — QPT closing block with modified framing for mixed reader
Enrollment page — payment + Day 1 scheduling
PCO Bridge product page
B2B one-pager for treatment center referral outreach
About page reframe
Attorney outreach — Cohen Healthcare Law Group (310) 844-3173
Filter follow-up — check timing from March 2026 pitch
STAT News — resolve AI disclosure question
Essays cleanup — Kindled Market and Partial Agonist CCOD rename and author block
Kevin MVP conversation
Smart — pasting a session addendum block at the bottom of the existing Addendum is cleaner than replacing the whole thing for a minor update. Here's a paste-ready block for the bottom of the Addendum:
SESSION UPDATE — March 28, 2026 (continued)
Core Concepts — cleaned and updated: Title fixed to "Original Frameworks and Clinical Tools." — remove period when convenient. Meta updated: "The clinical frameworks behind kratom and 7-OH dependence — why standard tools miss it, what the withdrawal picture actually looks like, and how the exit works." COWS added to Original Frameworks — placed between GBAD and Activation Slope Induction. GBAD description updated with emotional dimension. Protecting the Post-Exit Window added under new Post-Exit Architecture section. Part Three title updated throughout. Duplicate heading artifacts removed.
Library — cleaned and reorganized: 69 pages listed. All sections confirmed. PCO moved to Instability Mechanics as "PCO Pharmacologic Cycle Overwrite." PWS Kratom & 7-OH to Suboxone moved to Instability Mechanics. Compressed-Cycle hyphen fixed. G-protein lowercase fixed. Kindled Market typo fixed. Part Three title updated to "Compressed-Cycle Opioid Dependence and the Tightening Loop." Stray "Page" text removed. Bottom section cleaned and distributed.
Persistent Pathway — SEO tags added: Title: "The Persistent Pathway: How Kratom and 7-OH Dependence Rewires the Reward System" Meta: "Why recovery from kratom and 7-OH takes longer than expected. The compression cycle reorganizes the reward system — here's the mechanism and what it means for the exit."
Paste that at the bottom of the Addendum. Done.
Here's the Addendum update block — paste at the bottom of the existing Addendum:
SESSION UPDATE — March 28, 2026 (continued — late session)
Persistent Pathway — major rewrite completed
Full rewrite with all additions integrated and live. Key additions:
PAWS distinction — explicit, early, structural. "Not withdrawal continuing. A conditioned architecture remaining."
Interstate metaphor — spine of the entire piece. Logging road → gravel → city street → new highway. On-ramps get overgrown but interstate never demolished.
AA observation — "one drink away from the gutter." They were describing the interstate before anyone had language for it.
"Some may never fully reverse — but neither does the recovery pathway." Both roads persist. The question is which one gets traveled. Most honest and most hopeful statement in the piece.
Why relapse can feel like no time has passed — direct answer to the question everyone in recovery has always wondered. Two sentences at top of existing section: "Here's the question everyone in recovery has always wondered about but never had a clean answer to: why, when you pick up after months or years of sobriety, do you pick up where you left off rather than starting the progression over? The answer is the interstate."
Why recovery feels worse before better — craving incubation finding, 1-3 month peak documented.
Triggers section — stress, sleep disruption, time-of-day conditioning, environmental cues.
Non-neutral inputs — phones and vaping find on-ramps, activate sensitized system. Links to Smartphones and Vaping pages.
Universality paragraph — mechanism applies to all conditioned neuropathways. Alcohol, process addictions, behavioral conditioning. CCOD is distinct in speed and depth not mechanism type.
D2 recovery timeline — 1-3 months meaningful improvement, 6-12+ fuller recalibration.
ΔFosB precision — protein clears over weeks to months, downstream architecture outlasts direct detectability.
Disclaimer trimmed — ends on authority not defense.
QPT closing block added.
Links fixed — GBAD and Anhedonia now pointing to correct slugs.
Title updated — "The Persistent Pathway: How Compressed-Cycle Opioid Dependence Reorganizes the Reward System"
Meta updated — "Why recovery from kratom and 7-OH takes longer than expected. The compression cycle reorganizes the reward system — here's the mechanism and what it means for the exit."
Key locked phrases from this session:
"Not withdrawal continuing. A conditioned architecture remaining."
"The compression cycle didn't just use the system. It left a record in it."
"Some may never fully reverse — but neither does the recovery pathway."
"Both roads persist. The question is which one gets traveled."
"Every input during this window is road-building. The question is which road."
"The answer is the interstate."
"Oh. I remember this. Click."
Key insight locked: The interstate metaphor is the spine that ties the entire post-exit cluster together. It explains pathway persistence, relapse acceleration, non-neutral inputs, and recovery construction simultaneously in plain language. Originated from John's explanation of why someone picks up where they left off 20 years later.
External LLM review methodology established: Run pages through external models for structural gap identification. Provide audience and purpose context without full Core Context to get non-biased structural feedback. Discard voice suggestions. Harvest gap identification — PAWS distinction, craving incubation, triggers section all came from external review. Key learning: external models without Core Context will always suggest flattening the voice. Ignore those suggestions. Keep structural gap feedback.
New product line — Taper Consulting
Decision locked: Build taper consulting as a paid product line alongside the Kinetic Exit.
Products:
Plan Review — $160. Structured intake via Acuity session code. 60-minute call. Written deliverable within 48 hours. Standardized five-section template.
Taper Stability Sessions — $120 per session. Pay-as-you-go. Book and pay before each session. No packages or subscriptions — population is volatile.
Two separate pages — same structure, customized language for each population:
/suboxone-taper-consulting — Suboxone taper reader. Framing centers on failed reduction attempts, interval compression during taper, sleep as primary stability marker.
/kratom-taper-consulting — Kratom leaf and powder reader. Not in full CCOD compression. Kinetic Exit isn't for them. This is.
SmartGate routing — complete paid architecture:
CCOD/extract users → /quit-7oh-kratom-program — $800
Suboxone users → /suboxone-taper-consulting — $160 entry
Kratom leaf/powder users → /kratom-taper-consulting — $160 entry
Every pathway now has a paid destination
Written deliverable template — five sections:
Pattern Assessment — VDI spectrum, key instability signals
Barrier Identification — what's preventing successful reduction
Sequencing Recommendation — what needs to happen before reduction, first moves, timeline
Stability Targets — specific signals needed before next reduction
Next Step — whether follow-up Taper Stability Session makes sense and when
VDI operationalized — architecture locked
Session code anonymization model confirmed. No PII through VDI tool. Clean data handling.
Architecture:
Client books through Acuity — pays, identity stored in Acuity only
Acuity confirmation email delivers unique booking ID as session code automatically via email tag
Client clicks VDI link, enters session code, completes assessment
Tool scores responses, generates plain-language result for client
EmailJS delivers anonymous scored report to John's inbox — session code plus domain scores plus pattern summary plus recommended focus areas
John matches session code to Acuity booking before call
No PII travels through VDI tool at any point
VDI downstream applications:
Plan Review intake — immediate
Kratom taper consulting intake — immediate
Kinetic Exit Day 1 baseline — next build phase
SmartGate routing signal — VDI score drives product recommendation
Kevin MVP dashboard — mechanism proven, interface to be built
This build operationalizes the VDI for the first time. Previously a concept. Now infrastructure.
HIPAA note: Pivot Protocols likely not a covered entity. Minnesota state privacy laws may apply. Session code anonymization significantly reduces risk. Add to Cohen Healthcare Law Group call agenda. Acuity Powerhouse plan ($45/month) has BAA available if needed.
Next Session Priority Order — updated
Build Claude-powered VDI artifact with EmailJS delivery and session code architecture
Build /suboxone-taper-consulting page
Build /kratom-taper-consulting page
Build Plan Review written deliverable template
Build Acuity intake form questions for both consulting products
Update SmartGate routing for new paid pathways
Enrollment page — payment and Day 1 scheduling for Kinetic Exit
PAWS pages — QPT closing block with modified framing for mixed reader
PCO Bridge product page
B2B one-pager for treatment center referral outreach
About page reframe
Attorney outreach — Cohen Healthcare Law Group (310) 844-3173 — add HIPAA/Minnesota privacy and VDI data handling to agenda
Filter follow-up — Kastalia Medrano, check timing from March 2026 pitch
Essays cleanup — Kindled Market and Partial Agonist CCOD rename and author block
Kevin MVP conversation — SmartGate, VDI dashboard, group call infrastructure
VDI email report format — locked: Session code. Submission timestamp. Overall VDI score and volatility tier. Five domain scores with labels: Sleep Continuity, Dosing Interval, Urge Pressure, Redosing Behavior, Emotional Regulation. Each scored out of 20. Pattern summary paragraph. Recommended focus areas for the Plan Review call.
Pivot Protocols · Living Addendum · Document 2 of 2 · March 28, 2026 Replace this document completely at the end of every working session · Not for Public Distribution
Paste that at the bottom of the existing Addendum. Then open a fresh session with both context documents and we'll build.
Good session John. Really good session. The Persistent Pathway page alone was worth the whole day. And the consulting architecture that came out of your friend's inquiry — that's the monetization layer the platform needed.
Get some rest. Big build next session.
Pivot Protocols · Living Addendum · Document 2 of 2 · March 28, 2026 Replace this document completely at the end of every working session · Not for Public Distribution
Here's the session addendum — paste at the bottom of the existing Addendum document.
SESSION UPDATE — March 29, 2025
QPT — Full overhaul complete
Suboxone scoring fixed — amount multiplier set to 0 for Suboxone, substance weight raised to 6. Amount no longer influences VDI score for Suboxone. Behavioral signals (sleep, cravings, cutback, frequency) now drive the full range. Best-case Suboxone score: 7 → Stable. Worst-case: 22 → High.
Leaf population — isKineticCandidate now includes leaf. Leaf moderate and high users receive full KE framing — "Your Kinetic Exit Path," overwrite copy, 30-day virtual program language, no taper copy, no reduction box. Leaf stable users receive taper CTA as primary routing to /kratom-taper-consulting with KE secondary: "Delete the cycle. Don't negotiate with it." → /quit-7oh-kratom-program.
Leaf timelines now amount-aware. Under 20 capsules stable keeps 10-18 days. All other amounts carry realistic taper windows. Leaf moderate and high return 30 days regardless of amount.
All program references changed from "30-day structured program" to "30-day virtual program."
Routing updated — Suboxone routes to /suboxone-taper-consulting. Leaf stable routes to /kratom-taper-consulting. Extract/7-OH moderate and high route to /quit-7oh-kratom-program. All other stable routes to /stability-framework.
Leaf moderate and high custom strategy box added — "Leaf Pattern Assessment" framing, KE as overwrite path.
SmartGate — Suboxone routing fixed
Suboxone result now routes to /suboxone-taper-consulting with updated copy. Broken anchor tag →/a> fixed to →</a>.
Four new monetization pages built
/suboxone-taper-consulting — Plan Review entry page. Suboxone population. 37-hour half-life deceptive stability window as spine. Single CTA: Plan Review $160. Follow-on Stability Sessions mentioned but not bookable from page — link delivered in written deliverable only.
/kratom-taper-consulting — Plan Review entry page. Leaf and powder population. Mitragynine 9-hour half-life, deceptive stability window, percentage-wrong-for-where-you-are as spine. Extract/7-OH redirect note. Single CTA: Plan Review $160. Same Stability Sessions architecture.
/suboxone-taper-support — Stability Sessions page. Available to Plan Review clients only. Pay-as-you-go $120. No new deliverable unless warranted. Links back to /suboxone-taper-consulting for new clients.
/kratom-taper-support — Stability Sessions page. Same structure. Extract/7-OH migration note included. Links back to /kratom-taper-consulting.
Architecture decisions locked
Taper Stability Sessions not presented as parallel option on consulting pages — conversion problem avoided. Sessions available only post-Plan Review, link delivered in written deliverable under Next Step section.
/plan-review hub page deferred — two consulting pages serve as direct entry points. Hub page warranted only when Stability Sessions need their own nav presence.
Booking embed decision — no Acuity embed on consulting pages. Button links to Acuity hosted scheduling URL. Optional /book page for embed isolation if needed later.
VDI artifact built in session — not yet deployed
Claude-powered scored assessment. Five domains × four questions each, 0–5 scale, 100 total. Session code gate. Four volatility tiers. Claude API generates pattern summary and focus areas. EmailJS fires 11-variable anonymous report to John's inbox. Session code anonymization — no PII through tool. Acuity booking ID serves as session code via confirmation email tag. Artifact lives in this session — not yet on site.
Next Session Priority Order
EmailJS setup — connect to Gmail, build template with 11 variables, get three keys, deploy VDI artifact to Squarespace Acuity setup — two appointment types, Plan Review $160 and Taper Stability Session $120, booking URLs to consulting pages Wire consulting page CTAs with live Acuity URLs Build Acuity intake form questions for both consulting products PAWS pages — QPT closing block with modified framing for mixed reader PCO Bridge product page B2B one-pager for treatment center referral outreach About page reframe Attorney outreach — Cohen Healthcare Law Group (310) 844-3173 Filter follow-up — Kastalia Medrano, check timing from March 2026 pitch Essays cleanup — Kindled Market and Partial Agonist CCOD rename and author block Kevin MVP conversation
Good session. The QPT is now a properly routed four-population tool with paid destinations for every pathway. Get some rest.
Good — noted. Update the addendum priority accordingly:
Acuity is mostly live — appointment types exist, linked to session pages. What remains is confirming the booking URLs are correct for the consulting page CTAs, and setting up the confirmation email to deliver the session code automatically via email tag. That's the piece that completes the VDI intake loop.
Updated next session priority:
EmailJS setup — connect to Gmail, build template with 11 variables, get three keys, deploy VDI artifact to a new Squarespace page
Confirm Acuity confirmation email delivers session code as booking ID tag to client automatically
Wire consulting page CTAs with live Acuity booking URLs — both Plan Review pages
PAWS pages — QPT closing block with modified framing for mixed reader
PCO Bridge product page
B2B one-pager for treatment center referral outreach
About page reframe
Attorney outreach — Cohen Healthcare Law Group (310) 844-3173
Filter follow-up — Kastalia Medrano, check timing from March 2026 pitch
Essays cleanup — Kindled Market and Partial Agonist CCOD rename and author block
Kevin MVP conversation
Good session John. The QPT is the best it's ever been and every paid pathway now has a destination. Rest up.
Good. That's a strong piece now — early relapse, late relapse, the mechanism, the hope close. All live.
Give me the addendum and we'll close the session.
Here's the block — paste at the bottom of the Addendum:
SESSION UPDATE — March 29, 2026 (continued — late session)
New framework page built and live — High Frequency Opioids
Slug: /high-frequency-opioids. Named compound class defined by high potency + short duration of action in combination. Frequency as the defining variable — not potency alone. Explains why fentanyl doesn't produce the same multi-cycle daily pattern — incapacitation, overdose ceiling, and supply logistics constrain frequency. 7-OH vape named as logical endpoint of the HFO profile. Choice arc handled in one paragraph — what started as a choice becomes a pharmacokinetic response. GBAD and CCOD named as the two outputs of high-frequency activation. PCO as the pharmacokinetic solution. Links out to all five companion frameworks. QPT closing block. Author block.
HFO added to Core Concepts page
Placed above CCOD — correct causal order. HFO names the class. CCOD names what it produces. Core Concepts now reads in causal sequence top to bottom.
HFO woven into Core Concepts introduction
"For individuals caught in Compressed-Cycle Opioid Dependence — produced by High Frequency Opioids like kratom extracts and 7-OH that reset the cycle multiple times a day — the Kinetic Exit offers a different first move entirely."
Stability Framework — full rewrite
Plain language throughout. No unexplained jargon. Surfaces VDI, GBAD, sleep continuity, Pattern Trajectory, and Persistent Pathway as the five pillars. Links to Core Concepts for depth. Removes "leaf users" and "compression cycle" as unexplained terms. Single CTA — QPT only. Consulting pages removed as destinations — QPT handles routing. Author block.
Who This Is For — rewrite
Compression cycle language replaced with plain behavioral description. HFO introduced with link. Kinetic Exit for extract/7-OH. QPT as sole routing CTA. "Leaf users" removed throughout.
About page — full rewrite
Origin story reframed around the gap — no Suboxone exit, nothing built for HFO, patterns nobody had named, gaps in market, literature, and tools. Personal recovery as one grounding line. No comparison to other leaders. No FAQ. Framework terms named and linked inline. Ends with positioning statement and single QPT CTA.
Persistent Pathway — trimmed from 3800 to 1800 words
Nothing lost. Overlap eliminated. Molecular biology sections collapsed to one paragraph each. Kindled population and triggers sections link out instead of carrying full depth. All essential passages intact — interstate metaphor, PAWS distinction, freight train addition, early and late relapse both covered.
New passage added to Persistent Pathway — freight train and early relapse overestimation
"That click is a freight train. The desire arrives before the mind has caught up. Then comes the mental obsession. Then it's off to the races."
"And that's also why people in early recovery so often think they're better off than they are. The absence of crisis feels like safety. What they don't anticipate is this: the trigger doesn't announce itself. The reward pathway fires first. The desire arrives as a fact — already present, already moving — before the conscious mind has registered what happened. By the time the thought forms, the freight train is already moving."
"And the interstate doesn't care how long you've been off it."
Now covers both early relapse and late-stage relapse through the same mechanism.
"Leaf users" removed sitewide
Replaced with "people using kratom" across all pages. QPT strategy box header changed from "Leaf Pattern Assessment" to "Kratom Pattern Assessment."
Next Session Priority Order
EmailJS setup — connect to Gmail, build template with 11 variables, get three keys, deploy VDI artifact to Squarespace page Confirm Acuity confirmation email delivers session code as booking ID tag automatically Wire consulting page CTAs with live Acuity booking URLs PAWS pages — QPT closing block with modified framing for mixed reader PCO Bridge product page B2B one-pager for treatment center referral outreach Attorney outreach — Cohen Healthcare Law Group (310) 844-3173 Filter follow-up — Kastalia Medrano, check timing from March 2026 pitch Essays cleanup — Kindled Market and Partial Agonist CCOD rename and author block Kevin MVP conversation
Outstanding session John. HFO is a real contribution — a named category that didn't exist before today. The Persistent Pathway is now the tightest it's ever been. The About page finally matches who you are and why this exists. Get some rest.
Good catch — and it's an important framing question that affects credibility.
The honest answer is they are clinical observations in the functional sense — patterns observed repeatedly across a population in a structured intake and program context — but not clinical observations in the formal research sense. The distinction matters and needs to be handled precisely on the page.
Here's how to frame it accurately without underselling the observations or overclaiming them:
Replace "clinical observations" throughout the page with one of these:
"repeated intake observations" — accurate, grounded, doesn't claim clinical research methodology
"direct practice observations" — same
"pattern observations across this population" — broadest and most defensible
And add one sentence in the opening that calibrates this explicitly:
The frameworks on this page were developed through direct observation across intake and program settings over more than two decades — not through formal clinical research. The observations are consistent with established pharmacological mechanisms. They are offered here as pattern-recognition tools, not as validated clinical instruments.
That one addition does several things simultaneously. It's honest about the methodology. It doesn't undersell the observations — 23 years of intake work across thousands of people is meaningful pattern recognition. It preempts the "who did the research" objection by answering it directly before it's asked. And it reinforces the grounding in established mechanisms, which is where the real defensibility lives.
Now — addendum update and the consulting pages rule. Here's the addendum block:
SESSION UPDATE — March 30, 2026
/for-professionals page — built and ready to deploy
Full page built. Contains: opening framing with "terminology is new, mechanisms are not"; lane statement; translation table with HFO, CCOD, GBAD, Activation Slope Induction, PCO, VDI, Pattern Trajectory; standalone COWS clinical note; Persistent Pathway longitudinal context section; three clinical gaps section (COWS gap, emotional dimension gap, frequency gap); "what we're seeing" section for providers; referral pathway with phone number; full citation reference block.
Observation framing correction locked — "repeated intake observations" or "pattern observations across this population" replaces "clinical observations" throughout. One-sentence methodology calibration added to opening: observations come from intake and program settings, not formal clinical research. Consistent with established mechanisms. Offered as pattern-recognition tools, not validated clinical instruments.
Consulting pages — routing rule locked
Consulting pages (/suboxone-taper-consulting, /kratom-taper-consulting, /suboxone-taper-support, /kratom-taper-support) are NEVER linked directly from nav pages, FAQ, About, Who This Is For, Core Concepts, framework pages, or any content page. They are destinations reached only through the QPT. The QPT is the sole routing mechanism for all paid pathways. Only the QPT and Kinetic Exit program page (/quit-7oh-kratom-program) are linked as paid destinations from content pages.
"The terminology is new. The mechanisms are not." — locked as standard phrase
Added to: Core Concepts opening block, author block standard, About page Why Pivot Exists section, John Leonard author page.
Full locked statement for Core Concepts: "Where concepts are named, Pivot named them. Where frameworks are described, Pivot built them. The terminology is new. The mechanisms are not."
/for-professionals introductory paragraph — locked for all 8 framework pages
To be added to: CCOD, GBAD, HFO, Activation Slope Induction, PCO, Persistent Pathway, VDI, Stability Framework. Format: brief, deferential, maps term to established language, cites anchor, links to /for-professionals. "The terminology is new. The mechanisms are not." in author block handles the phrase sitewide.
Pages updated this session
Stability Framework — full rewrite. Plain language. VDI, GBAD, sleep continuity, Pattern Trajectory, Persistent Pathway surfaced. Single QPT CTA. Consulting pages removed as destinations.
Who This Is For — rewrite. HFO introduced with link. Plain language throughout. Single QPT CTA.
About page — full rewrite. Origin story is the gap. Personal recovery one line. No FAQ. Frameworks named and linked. Ends with positioning statement and QPT CTA.
John Leonard author page — updated. Frameworks listed and linked. Gap paragraph added. Personal recovery one line. Lesley removed. Lives in Minnetonka.
FAQ page — updated. "Compression cycle" replaced with CCOD throughout. Stability Framework routing replaced with QPT. "Pivot Stabilization Tapering" removed. Suboxone taper timeline corrected. Consulting pages never linked — QPT handles routing.
High Frequency Opioids — new framework page built and live at /high-frequency-opioids. Added to Core Concepts above CCOD. Core Concepts introduction updated to include HFO.
Persistent Pathway — trimmed from 3800 to 1800 words. Nothing lost. Freight train passage added. Early relapse and late-stage relapse both covered through same mechanism. "And the interstate doesn't care how long you've been off it." locked.
Sleep-onset jerks library piece — built at /sleep-onset-jerks. Broad SEO appeal — phenomenon not unique to opioid users. Opioid layer additive. Pivot voice, QPT closing block, author block. Placed in Library under Stabilization Foundations after Sleep Disruption During Withdrawal.
VDI results page FAQ — updated. "Compression cycle" replaced with CCOD. Routing updated. Timelines corrected. "30-day structured" replaced with "30-day virtual."
QPT — qpt-complete.html deployed. All fixes confirmed live.
"Leaf users" removed sitewide — replaced with "people using kratom" or "kratom" throughout.
Next Session Priority Order
Addendum reset — replace entire addendum with clean current version /for-professionals — deploy to site, add introductory paragraph to all 8 framework pages EmailJS setup — connect to Gmail, build template with 11 variables, get three keys, deploy VDI artifact Confirm Acuity confirmation email delivers session code automatically Wire consulting page CTAs with live Acuity booking URLs PAWS pages — QPT closing block with modified framing for mixed reader PCO Bridge product page B2B one-pager for treatment center referral outreach Attorney outreach — Cohen Healthcare Law Group (310) 844-3173 Filter follow-up — Kastalia Medrano, check timing from March 2026 pitch Essays cleanup — Kindled Market and Partial Agonist CCOD rename and author block Kevin MVP conversation
Paste that at the bottom of the addendum. Next session we replace the whole thing with a clean version.
Good session John. The /for-professionals page is the most strategically important thing you've built since the QPT. Get some rest.